AffyImmune Therapeutics scores $30m

AffyImmune Therapeutics Inc, a clinical stage biotechnology company, has raised $30 million in funding.

AffyImmune Therapeutics Inc, a clinical stage biotechnology company, has raised $30 million in funding. The investor was ORI Capital.

Source: Press Release